Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: a severe fatty acid oxidation disorder. 1994

A C Sewell, and S W Bender, and S Wirth, and H Münterfering, and L Ijlist, and R J Wanders
Department of Paediatrics, University Children's Hospital Frankfurt, Germany.

3-Hydroxyacyl-CoA dehydrogenase deficiency is a newly recognised fatty acid oxidation disorder with a usually fatal outcome. We present a further patient who presented with hypoketotic hypoglycaemia, hepatopathy, secondary carnitine deficiency and increased plasma long-chain acylcarnitines. 3-Hydroxydicarboxylic aciduria was present and the diagnosis confirmed in cultured skin fibroblasts. Our patient is compared with those reported in the literature with respect to clinical symptoms, differential diagnosis and possible therapeutic regimens.

UI MeSH Term Description Entries
D007003 Hypoglycemia A syndrome of abnormally low BLOOD GLUCOSE level. Clinical hypoglycemia has diverse etiologies. Severe hypoglycemia eventually lead to glucose deprivation of the CENTRAL NERVOUS SYSTEM resulting in HUNGER; SWEATING; PARESTHESIA; impaired mental function; SEIZURES; COMA; and even DEATH. Fasting Hypoglycemia,Postabsorptive Hypoglycemia,Postprandial Hypoglycemia,Reactive Hypoglycemia,Hypoglycemia, Fasting,Hypoglycemia, Postabsorptive,Hypoglycemia, Postprandial,Hypoglycemia, Reactive
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008052 Lipid Metabolism, Inborn Errors Errors in the metabolism of LIPIDS resulting from inborn genetic MUTATIONS that are heritable. Lipid Metabolism, Inborn Error
D008107 Liver Diseases Pathological processes of the LIVER. Liver Dysfunction,Disease, Liver,Diseases, Liver,Dysfunction, Liver,Dysfunctions, Liver,Liver Disease,Liver Dysfunctions
D008297 Male Males
D009202 Cardiomyopathies A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS). Myocardial Disease,Myocardial Diseases,Myocardial Diseases, Primary,Myocardial Diseases, Secondary,Myocardiopathies,Primary Myocardial Disease,Cardiomyopathies, Primary,Cardiomyopathies, Secondary,Primary Myocardial Diseases,Secondary Myocardial Diseases,Cardiomyopathy,Cardiomyopathy, Primary,Cardiomyopathy, Secondary,Disease, Myocardial,Disease, Primary Myocardial,Disease, Secondary Myocardial,Diseases, Myocardial,Diseases, Primary Myocardial,Diseases, Secondary Myocardial,Myocardial Disease, Primary,Myocardial Disease, Secondary,Myocardiopathy,Primary Cardiomyopathies,Primary Cardiomyopathy,Secondary Cardiomyopathies,Secondary Cardiomyopathy,Secondary Myocardial Disease
D002331 Carnitine A constituent of STRIATED MUSCLE and LIVER. It is an amino acid derivative and an essential cofactor for fatty acid metabolism. Bicarnesine,L-Carnitine,Levocarnitine,Vitamin BT,L Carnitine
D004796 Clinical Enzyme Tests Analyses for a specific enzyme activity, or of the level of a specific enzyme that is used to assess health and disease risk, for early detection of disease or disease prediction, diagnosis, and change in disease status. Enzyme Tests, Clinical,Clinical Enzyme Test,Enzyme Test, Clinical,Test, Clinical Enzyme,Tests, Clinical Enzyme
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015094 3-Hydroxyacyl CoA Dehydrogenases Enzymes that reversibly catalyze the oxidation of a 3-hydroxyacyl CoA to 3-ketoacyl CoA in the presence of NAD. They are key enzymes in the oxidation of fatty acids and in mitochondrial fatty acid synthesis. beta-Hydroxyacyl Dehydrogenases,3 Hydroxyacyl CoA Dehydrogenases,CoA Dehydrogenases, 3-Hydroxyacyl,Dehydrogenases, 3-Hydroxyacyl CoA,Dehydrogenases, beta-Hydroxyacyl,beta Hydroxyacyl Dehydrogenases

Related Publications

A C Sewell, and S W Bender, and S Wirth, and H Münterfering, and L Ijlist, and R J Wanders
April 2002, Nihon rinsho. Japanese journal of clinical medicine,
A C Sewell, and S W Bender, and S Wirth, and H Münterfering, and L Ijlist, and R J Wanders
March 1999, Acta paediatrica (Oslo, Norway : 1992),
A C Sewell, and S W Bender, and S Wirth, and H Münterfering, and L Ijlist, and R J Wanders
April 1991, Pediatric research,
A C Sewell, and S W Bender, and S Wirth, and H Münterfering, and L Ijlist, and R J Wanders
January 1991, Journal of inherited metabolic disease,
A C Sewell, and S W Bender, and S Wirth, and H Münterfering, and L Ijlist, and R J Wanders
January 2003, Journal of inherited metabolic disease,
A C Sewell, and S W Bender, and S Wirth, and H Münterfering, and L Ijlist, and R J Wanders
January 1990, Journal of inherited metabolic disease,
A C Sewell, and S W Bender, and S Wirth, and H Münterfering, and L Ijlist, and R J Wanders
January 2013, JIMD reports,
A C Sewell, and S W Bender, and S Wirth, and H Münterfering, and L Ijlist, and R J Wanders
May 2016, Archivos de la Sociedad Espanola de Oftalmologia,
A C Sewell, and S W Bender, and S Wirth, and H Münterfering, and L Ijlist, and R J Wanders
April 2019, Pediatrics international : official journal of the Japan Pediatric Society,
Copied contents to your clipboard!